Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Is time from diagnosis to radical prostatectomy associated with oncological outcomes?

Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V.

World J Urol. 2018 Nov 27. doi: 10.1007/s00345-018-2570-6. [Epub ahead of print]

PMID:
30483947
2.

Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.

Heering M, Berg KD, Brasso K, Iversen P, Røder MA.

Surg Oncol. 2017 Mar;26(1):21-27. doi: 10.1016/j.suronc.2016.12.002. Epub 2016 Dec 8.

PMID:
28317581
3.

Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.

Pompe RS, Gild P, Karakiewicz PI, Bock LP, Schlomm T, Steuber T, Graefen M, Huland H, Tian Z, Tilki D.

Prostate. 2018 Jun;78(9):676-681. doi: 10.1002/pros.23511. Epub 2018 Mar 23.

PMID:
29570821
4.

Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.

Colicchia M, Morlacco A, Rangel LJ, Carlson RE, Dal Moro F, Karnes RJ.

Eur Urol Focus. 2018 Jan 3. pii: S2405-4569(17)30292-4. doi: 10.1016/j.euf.2017.12.005. [Epub ahead of print]

PMID:
29306730
5.

Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling?

Wæhre H, Vlatkovic L, Cvancarova M, Paus E, Fosså SD, Danielsen HE.

Scand J Urol. 2014 Apr;48(2):123-30. doi: 10.3109/21681805.2013.817483. Epub 2013 Jul 25.

PMID:
23885810
6.

Impact of surgical margin status on prostate-cancer-specific mortality.

Chalfin HJ, Dinizo M, Trock BJ, Feng Z, Partin AW, Walsh PC, Humphreys E, Han M.

BJU Int. 2012 Dec;110(11):1684-9. doi: 10.1111/j.1464-410X.2012.11371.x. Epub 2012 Jul 12.

7.

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV.

J Clin Oncol. 2005 Oct 1;23(28):6992-8.

PMID:
16192586
8.

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.

PMID:
25294696
9.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

10.

10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era.

Mendhiratta N, Lee T, Prabhu V, Llukani E, Lepor H.

Urology. 2015 Oct;86(4):783-8. doi: 10.1016/j.urology.2015.05.034. Epub 2015 Jul 9.

PMID:
26163812
11.

Predictors of prostate cancer specific mortality after radical prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy Registry.

Bolton DM, Papa N, Ta AD, Millar J, Davidson AJ, Pedersen J, Syme R, Patel MI, Giles GG.

BJU Int. 2015 Oct;116 Suppl 3:66-72. doi: 10.1111/bju.13112.

12.

External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.

Wang C, Kishan AU, Kamrava M, Steinberg ML, King CR.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1045-1052. doi: 10.1016/j.ijrobp.2017.03.040. Epub 2017 Mar 31.

PMID:
28721887
13.

20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.

Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, Karnes RJ.

BJU Int. 2012 Dec;110(11):1709-13. doi: 10.1111/j.1464-410X.2012.11372.x. Epub 2012 Aug 30.

14.

Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis.

Watkins JM, Mitchell DL, Russo JK, Mott SL, Tracy CR, Smith MC, Buatti JM.

Clin Genitourin Cancer. 2017 Apr;15(2):242-247. doi: 10.1016/j.clgc.2016.05.016. Epub 2016 May 29.

PMID:
27338519
15.

Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.

Loeb S, Zhu X, Schroder FH, Roobol MJ.

BJU Int. 2012 Dec;110(11):1678-83. doi: 10.1111/j.1464-410X.2012.11367.x. Epub 2012 Sep 21.

16.

New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.

Ham WS, Chalfin HJ, Feng Z, Trock BJ, Epstein JI, Cheung C, Humphreys E, Partin AW, Han M.

Eur Urol. 2017 Jun;71(6):907-912. doi: 10.1016/j.eururo.2016.11.006. Epub 2016 Nov 19.

PMID:
27876305
17.

Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRI.

Woo S, Cho JY, Ku JH, Kim SY, Kim SH.

Acta Radiol. 2016 Aug;57(8):1006-13. doi: 10.1177/0284185115610933. Epub 2015 Oct 26.

PMID:
26508791
18.

Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely?

Fossati N, Rossi MS, Cucchiara V, Gandaglia G, Dell'Oglio P, Moschini M, Suardi N, Dehò F, Montorsi F, Schiavina R, Mottrie A, Briganti A.

Urol Oncol. 2017 Apr;35(4):150.e9-150.e15. doi: 10.1016/j.urolonc.2016.11.010. Epub 2016 Dec 13.

PMID:
27986374
19.

Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.

Moschini M, Sharma V, Zattoni F, Quevedo JF, Davis BJ, Kwon E, Karnes RJ.

Eur Urol. 2016 Jan;69(1):135-42. doi: 10.1016/j.eururo.2015.03.036. Epub 2015 Apr 10.

PMID:
25865061
20.

Does time from diagnosis to treatment of high or very high risk prostate cancer affect outcome?

Reichard CA, Nyame YA, Sundi D, Tosoian J, Wilkins L, Alam R, Achim MF, Wang X, Stephenson AJ, Klein EA, Ross AE, Davis JW, Chapin BF.

BJU Int. 2019 Jan 17. doi: 10.1111/bju.14671. [Epub ahead of print]

PMID:
30653804

Supplemental Content

Support Center